Anchor Investment Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.1K | Hold |
160
| – | – | ﹤0.01% | 676 |
|
|
2025
Q4 | $30.3K | Hold |
160
| – | – | ﹤0.01% | 673 |
|
|
2025
Q3 | $26.5K | Hold |
160
| – | – | ﹤0.01% | 693 |
|
|
2025
Q2 | $24.5K | Hold |
160
| – | – | ﹤0.01% | 693 |
|
|
2025
Q1 | $25.2K | Hold |
160
| – | – | ﹤0.01% | 673 |
|
|
2024
Q4 | $25.1K | Hold |
160
| – | – | ﹤0.01% | 677 |
|
|
2024
Q3 | $28.4K | Hold |
160
| – | – | ﹤0.01% | 651 |
|
|
2024
Q2 | $26.9K | Hold |
160
| – | – | ﹤0.01% | 601 |
|
|
2024
Q1 | $26.6K | Hold |
160
| – | – | ﹤0.01% | 628 |
|
|
2023
Q4 | $26.4K | Hold |
160
| – | – | ﹤0.01% | 614 |
|
|
2023
Q3 | $24.9K | Sell |
160
-5
| -3% | -$799 | ﹤0.01% | 622 |
|
|
2023
Q2 | $25.7K | Hold |
165
| – | – | ﹤0.01% | 614 |
|
|
2023
Q1 | $26.7K | Hold |
165
| – | – | ﹤0.01% | 620 |
|
|
2022
Q4 | $26.4K | Hold |
165
| – | – | ﹤0.01% | 606 |
|
|
2022
Q3 | $23.2K | Hold |
165
| – | – | ﹤0.01% | 608 |
|
|
2022
Q2 | $24.1K | Hold |
165
| – | – | ﹤0.01% | 624 |
|
|
2022
Q1 | $26.8K | Hold |
165
| – | – | ﹤0.01% | 626 |
|
|
2021
Q4 | $31.2K | Hold |
165
| – | – | ﹤0.01% | 626 |
|
|
2021
Q3 | $33.4K | Buy |
165
+10
| +6% | +$2.1K | ﹤0.01% | 570 |
|
|
2021
Q2 | $31.3K | Hold |
155
| – | – | ﹤0.01% | 598 |
|
|
2021
Q1 | $27.2K | Hold |
155
| – | – | ﹤0.01% | 590 |
|
|
2020
Q4 | $26.3K | Hold |
155
| – | – | ﹤0.01% | 561 |
|
|
2020
Q3 | $25.1K | Hold |
155
| – | – | 0.01% | 536 |
|
|
2020
Q2 | $25.3K | Hold |
155
| – | – | 0.01% | 523 |
|
|
2020
Q1 | $19.8K | Hold |
155
| – | – | 0.01% | 538 |
|
|
2019
Q4 | $21.6K | Hold |
155
| – | – | ﹤0.01% | 560 |
|
|
2019
Q3 | $18.3K | Hold |
155
| – | – | ﹤0.01% | 572 |
|
|
2019
Q2 | $20K | Hold |
155
| – | – | ﹤0.01% | 561 |
|
|
2019
Q1 | $19.9K | Hold |
155
| – | – | 0.01% | 556 |
|
|
2018
Q4 | $17.2K | Hold |
155
| – | – | ﹤0.01% | 562 |
|
|
2018
Q3 | $21.1K | Hold |
155
| – | – | ﹤0.01% | 565 |
|
|
2018
Q2 | $18.6K | Hold |
155
| – | – | ﹤0.01% | 591 |
|
|
2018
Q1 | $18.7K | Hold |
155
| – | – | ﹤0.01% | 575 |
|
|
2017
Q4 | $19.3K | Hold |
155
| – | – | 0.01% | 568 |
|
|
2017
Q3 | $20.8K | Hold |
155
| – | – | 0.01% | 551 |
|
|
2017
Q2 | $19.5K | Hold |
155
| – | – | 0.01% | 497 |
|
|
2017
Q1 | $18.5K | Buy |
+155
| New | +$18.1K | 0.01% | 495 |
|
Other funds holding BBH
MIM
CCA
BFG
Anchor Investment Management's BBH Position: Q1 2026 in Review
Anchor Investment Management held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 160 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #676.
Anchor Investment Management first reported a position in BBH in Q1 2017 and has held it in 37 quarters since. The position peaked at $33.4K in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Anchor Investment Management held 160 shares of VanEck Biotech ETF worth $30.1K as of Q1 2026.
- Anchor Investment Management left its VanEck Biotech ETF share count unchanged in Q1 2026.
- VanEck Biotech ETF made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #676 holding.
- Anchor Investment Management first reported a position in VanEck Biotech ETF in Q1 2017 and has held it in 37 quarters since.
- Anchor Investment Management's VanEck Biotech ETF position peaked at $33.4K in Q3 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.